Anti-angiogenic peptides for treating or preventing endometriosis

US7645735B2 · kind B2 · utility

Assignee

• Children's Medical Center Corporation · US

Inventors

• Judah Folkman · Brookline, US
• Kashi Javaherian · Heidelberg, DE
• Christian Becker · Ratingen, DE
• Robert D'Amato · Cambridge, US

Key dates

• Filing date: Feb 28, 2006
• Grant date: Jan 12, 2010
• Expiry date: May 8, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K14/78
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are peptides from the N-terminal of endostatin proteins, including the first histidine of the protein, nucleic acids encoding the peptides, pharmaceutical compositions comprising the nucleic acids and proteins and methods for using the pharmaceutical compositions to treat or prevent endometriosis in a subject.